Pentwater Capital Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Pentwater Capital Management’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-3,200,000	Closed	-$218M	–	179
2022 Q3	$218M	Buy	+3,200,000	New	+$176M	2.44%	11
2019 Q3	–	Sell	-11,420	Closed	-$601K	–	208
2019 Q2	$601K	Buy	+11,420	New	+$656K	0.01%	152

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Pentwater Capital Management's GBT Position: Q4 2022 in Review

Pentwater Capital Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 3,200,000 shares — an estimated $218M sold.

Pentwater Capital Management first reported a position in GBT in Q2 2019 and held it in 2 quarters. The position peaked at $218M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

Pentwater Capital Management reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Pentwater Capital Management sold 3,200,000 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $218M.
Pentwater Capital Management first reported a position in Global Blood Therapeutics, Inc. in Q2 2019 and held it in 2 quarters.
Pentwater Capital Management's Global Blood Therapeutics, Inc. position peaked at $218M in Q3 2022.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Pentwater Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.